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The regulation of many protein kinases by binding to
calcium/calmodulin connects two principal mecha-
nisms in signaling processes: protein phosphoryla-
tion and responses to dose- and time-dependent
calcium signals. We used the calcium/calmodulin-
dependentmembers of the death-associated protein
kinase (DAPK) family to investigate the role of a basic
DAPK signature loop near the kinase active site. In
DAPK2, this loop comprises a novel dimerization-
regulated calcium/calmodulin-binding site, in addi-
tion to a well-established calcium/calmodulin site
in the C-terminal autoregulatory domain. Unexpect-
edly, impairment of the basic loop interaction site
completely abolishes calcium/calmodulin binding
and DAPK2 activity is reduced to a residual level,
indicative of coupled binding to the two sites. This
contrasts with the generally accepted view that
kinase calcium/calmodulin interactions are autono-
mous of the kinase catalytic domain. Our data estab-
lish an intricatemodel ofmulti-step kinase activation
and expand our understanding of how calcium bind-
ing connects with other mechanisms involved in
kinase activity regulation.
INTRODUCTION
The human kinome comprises more than 500 protein kinases,
around 15% of which are predicted to be regulated by calcium/
calmodulin (Ca2+/CaM) binding (Manning et al., 2002). This type
of regulation establishes a crucial link between dose- and time-
dependent calcium signaling and central biological processes
such as memory potentiation and apoptosis (Harr and Distel-Structure 24, 851–861
This is an open access article undhorst, 2010; Wayman et al., 2011). Most predicted Ca2+/CaM-
dependent kinases comprise an approximately 40-residue autor-
egulatory domain (ARD)C-terminal to the catalytic kinase domain
(CD). For several of these kinases it has been shown that the ARD
binds Ca2+/CaM with high affinity (Yamniuk and Vogel, 2004).
Numerous structural studies of kinase ARD peptide-Ca2+/CaM
complexes illustrate how both CaM lobes wrap an extended
helical ARD segment that is structurally autonomous of the
neighboring CD (Dagher et al., 2011; Kuczera and Kursula,
2012). This conclusionwas confirmed by a structure of the proto-
typic calcium/calmodulin-dependent protein kinase II (CaMKII)-
Ca2+/CaM complex, in which the ARD-Ca2+/CaM-binding mod-
ule is entirely separate from the CaMKII CD (PDB: 2WEL) (Rellos
et al., 2010). Surprisingly, in the only other available structure of a
kinase-Ca2+/CaM complex, death-associated protein kinase 1
(DAPK1), the ARD-Ca2+/CaM-binding segment was loosely
associated with the DAPK1 CD (PDB: 2X0G) (de Diego et al.,
2010). These data suggested that this structure did not represent
an activated DAPK1 state and that activity regulation by Ca2+/
CaM binding could be more complex than previously thought.
Thus, the goal of this study was to investigate Ca2+/CaM binding
toDAPKs tounravel themechanismof activity regulationbyCa2+/
CaM binding.
Members of the DAPK family are generally involved in both
apoptotic and autophagy pathways (Bialik and Kimchi, 2006)
and share significant overall sequence similarity with myosin
light chain-related kinases and triple functional domain protein-
related kinases (Temmerman et al., 2013). These kinases all
have similar patterns of substrate specificity and mechanisms
of regulation, with about half of them binding to Ca2+/CaM.
DAPK1 and DAPK2 bind Ca2+/CaM through a closely related
ARD, which is inhibited by phosphorylation of an identical ARD
residue Ser308 in both kinases (Shani et al., 2001; Shohat
et al., 2001). They also contain a basic loop (BL) in the kinase
N lobe next to the kinase active site, which has been identified
as a DAPK-family-specific signature motif (Tereshko et al.,
2001). However, no direct involvement of the loop in DAPK, June 7, 2016 ª 2016 The Authors. Published by Elsevier Ltd 851
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Structures of hDAPK1, hDAPK2,
and hDAPK3 Dimers with an Identical
Arrangement
Upper panel, topology of CD (violet) and ARD (blue)
in hDAPK1 (PDB: 2XZS), hDAPK2 (PDB: 2A2A), and
hDAPK3 (PDB: 1YRP) sequences. The approxi-
mate locations of the BL (green) and the HP (yellow)
are also colored. A ruler indicates approximate
residue positions. For each structure, the two
monomers are depicted as ribbons under trans-
parent surface (violet, blue) showing the basic loop
(green), the HP helix aG (yellow), and the ARD
(blue). Each monomer is labeled. Dashed lines
represent flexible regions that are not supported
by electron density (for further details, see Tables
S1 and S2). The common dimer arrangement found
in all three kinases is equivalent to the starting state
on the very left in the cartoon presentation of
Figure 7.catalysis has been detected (Velentza et al., 2001). Homodime-
rization of the DAPK1 CD has been shown in solution by mass
spectrometry (Zimmermann et al., 2010); however, the functional
relevance of this observation and the type of structural arrange-
ment are unknown. For DAPK3, canonical kinase domain-medi-
ated homodimeric assembly via activation loop swapping has
been reported (Pike et al., 2008). This type of dimeric assembly
is found in a broad range of serine/threonine protein kinases,
which require activation by phosphorylation within the CD acti-
vation segment (Oliver et al., 2007).
The remaining C-terminal domain organization varies between
members of the DAPK family, and distinct modes of kinase activ-
ity regulation have been reported for each DAPK (Carlessi et al.,
2011; Chen et al., 2010; Jebelli et al., 2012; Llambi et al., 2005).
DAPK2 comprises an additional C-terminal tail segment that
is predicted to be unstructured, and which has been shown
to contribute to kinase activation via another dimerization mech-
anism that has not yet been fully characterized (Shani et al.,
2001). Recent data indicate that this mode of activation
can be suppressed by phosphorylation-dependent binding of
14-3-3 scaffold proteins to the C-terminal DAPK2 tail (Gilad
et al., 2014) (Yuasa et al., 2015). However, structural studies of
the mouse DAPK2 have revealed a CD-mediated homodimeric
arrangement that is incompatible with a DAPK2 C-terminal-
mediated dimer arrangement (Patel et al., 2011).
Here, we first investigated whether the BL has a role in DAPK
activity and/or activity regulation. To address this question, we
analyzed and compared new structures of the three most closely
related human members of this family: hDAPK1, hDAPK2, and
hDAPK3. We found an identical type of dimer arrangement in
all three kinases that involves the BL of the CD. By making use
of engineered dimer interface mutations in hDAPK2, we found
that the BL not only contributes to CD-mediated dimerization
but also provides a previously unobserved Ca2+/CaM interaction
site. When this site is mutated, Ca2+/CaM binding and hDAPK2
activity are completely abolished, demonstrating that the estab-
lished mechanism of activity regulation involving the ARD is not
autonomous. The mechanism of dual Ca2+/CaM binding un-
raveled here has features reminiscent of Ca2+/CaM trapping
in CaMKII, where catalytic activity is regulated via differential852 Structure 24, 851–861, June 7, 2016Ca2+/CaM binding coupled with oligomerization and autophos-
phorylation. Such conservation of key features in these distantly
related kinases indicates that differential Ca2+/CaM binding
could play an important role in many more Ca2+/CaM-regulated
kinases and could form a link between kinase activation and
Ca2+ signaling.
RESULTS
Human DAPKs Share a Common CD-Mediated Dimeric
Interface
To explore the molecular mechanisms involved in human DAPK
regulation, we expressed and purified truncated versions of
hDAPK1, hDAPK2, and hDAPK3. Both the hDAPK1 and hDAPK2
constructs encompass the CD and ARD segments. Since
hDAPK3 has no ARD, the hDAPK3 construct we used was
limited to the CD. All three kinases were crystallized and the re-
sulting structures were refined to a resolution of 2.0 A˚ (hDAPK1),
1.47 A˚ (hDAPK2), and 3.1 A˚ (hDAPK3) (Figure 1 and Table 1). The
structures presented here all crystallized in the same dimeric
arrangement. In this contribution we thought it would be worth
investigating this type of dimerization interface further in terms
of potentially common functional implications, as such an inter-
face had not yet been previously discovered as a general pattern
in different members of the DAPK family.
The hDAPK2 crystal contained two of these dimers per
asymmetric unit, referred to as chains A/B and C/D, which pro-
vided an additional assessment of experimental error (Figure 1
and Table S1, details described in the legend). The root-mean-
square deviation (RMSD) values of superimposed dimers from
the different hDAPKs are in the range of 1.2–2.0 A˚, demon-
strating that the type of dimerization observed in the structures
of hDAPK1, hDAPK2, and hDAPK3 is conserved. The dimeric
interface areas are in the range of 930–1,600 A˚2 in size (Figure 1
and Table S2). This area is smaller in the DAPK1 dimer than in
the DAPK2 and DAPK3 dimers, as we were unable to model
most of the BL region in this kinase due to weak electron
density.
In all three DAPK structures, these interfaces comprise two
main surface areas. The first one is formed from residues of
Table 1. X-Ray Data Collection and Refinement of hDAPK1,
hDAPK2, and hDAPK3 Structures
Protein Kinase hDAPK1 hDAPK2 hDAPK3
PDB ID 2XZS 2A2A 1YRP
Data Collection
X-ray beamline ESRF,
ID14-4
EMBL/
DESY,
BW7A
EMBL/
DESY, X11
Wavelength (A˚) 0.9765 0.9206 0.81
No. of reflections 46,826 200,389 10,171
Completeness (%) 95.6
(89.9)
94.8
(93.4)
97.2
(95.5)
Redundancy 3.6 (3.5) 2.5 (1.9) 3.1 (3.0)
Resolution range (A˚) 50–2.0
(2.1–2.0)
40–1.47
(1.52–1.47)
20–3.1
(3.2–3.1)
Rsym (%) 7.5 (33.8) 4.9 (42.4) 9.8 (33.6)
<I/s> 11.5 (3.5) 11.1 (1.9) 11.3 (3.7)
Space group P21 P1 P21
Unit cell edges (A˚) 56.3, 49.6,
130.5
55.3, 60.7,
98.7
53.6, 60.9,
88.0
Unit cell angles () 90.0, 94.5,
90.0
92.2, 103.5,
94.3
90.0, 92.2,
90.0
Refinement
Resolution range (A˚) 43–2.0
(2.05–2.00)
20–1.47
(1.51–1.47)
20–3.1
(3.2–3.1)
Rcryst/Rfree (%) 18.5/22.5 15.0/20.7 24.5/26.8
No. of protein atoms 4,675 9,884 4,490
No. of heterogen atoms 2 61 8
No. of solvent atoms 243 1,371 0
Mean B value (A˚2) 30.8 23.6 47.2
RMSD bond lengths (A˚) 0.024 0.017 0.006
RMSD bond angles () 1.825 1.599 1.24
Ramachandran values
favored/allowed (%)
96.9/3.1 95.4/3.6 90.3/7.7
Data in parentheses correspond to the highest-resolution shell.the substrate-binding region and helix aG from the C lobe of
the CD, and the interactions constituting it are mainly hydropho-
bic, termed the hydrophobic patch (HP) (Figures 2 and 3). This
area is highly similar in terms of sequence and rigid structural
conformation in all the DAPK structures described here. The
second main dimer interface is formed from positively charged
residues on the DAPK signature BL segment, which belongs to
the most mobile areas in the DAPK structures. In DAPK2, the
main residues that contribute to the polar interactions are
Arg47, Arg50, and Arg53 as well as the active-site residue
Glu100 and Asp220 from the loop preceding helix aG (Figure 2).
In the DAPK3 structure, in which the BL residue 50 is a
serine instead of an arginine (Figure 3), the most specific inter-
actions are formed by Arg53 and residues C-terminal to the
BL from helix aC: Ser57 and Glu60. In DAPK3 there is an
additional specific interaction with Glu182, which is the central
residue of the PEF/Y motif and a key contributor to DAPK
substrate recognition (Figure S1) (Temmerman et al., 2014).
By contrast, in the DAPK2 structure, Glu182 is blocked by aninteraction with Arg303 from the ARD, which acts as a
pseudosubstrate.
In terms of functional implications, CD dimerization in hDAPK1,
hDAPK2, and hDAPK3 is likely to inhibit catalytic activity by
directly occluding the kinase active site. Furthermore, we
observed that this CD dimer interface largely overlaps with that
used for interactions with Ca2+/CaM, as also seen in the earlier
structure of the hDAPK1-Ca2+/CaM complex (de Diego et al.,
2010). A more detailed analysis revealed five overlapping surface
patches thatwe termed I toV. Twoof them, II and IV, coincidewith
the two main CD dimerization interfaces: the BL-mediated inter-
face (II) and the HP interface (IV). These two patches contribute
to more than half of the overall dimer interface area (Figure 3
and Table S2). There are two other segments, I and III, that
play prominent roles in Ca2+/CaM binding, but they show only
minor contributions in DAPK CD dimer interface formation.
Finally, there is the N-terminal part of the ARD that participates
in both CD dimer formation and the well-established ARD-medi-
ated Ca2+/CaM binding, defined as interface segment V. Based
on these observations, we investigated whether DAPK dimeriza-
tion might contribute to the regulation of Ca2+/CaM binding. We
addressed this question using hDAPK2, as its high-resolution
structure provides the most accurate data on dimer interface
interactions.
Structure-Based Design of hDAPK2 Mutants for
Functional Experiments
To explore the relevance of the dimeric arrangement, we de-
signed a number of mutants to reduce or abolish dimerization.
To ascertain whether hDAPK2 dimerization affects Ca2+/CaM
binding, we chose residues from segments that contribute to
interactions with Ca2+/CaM as well as homodimerization (de
Diego et al., 2010) (Figure 3). We first targeted the basic loop
(Figures 2 and 3) by mutating Arg47, Arg50, Arg53, and Arg54
to glutamate, and we refer to this as the ‘‘BL mutant.’’ We
selected this quadruple mutant, as all four BL residues are
involved in specific dimer interactions in the hDAPK2 structure.
Secondly we selected Asp220, which plays a consistent key
role in interacting with residues from the BL (Figure 2) but is
not involved in interactions with Ca2+/CaM. This residue was
changed to a lysine (D220K) (Figure 3). Thirdly we selected
Leu226, which also crucially contributes to homodimer in-
teractions with residues from the C-terminal lobe (Figure 2).
In contrast to the other residues selected for mutagenesis,
Leu226 is oriented toward the predicted kinase substrate-bind-
ing site (Figure S2). We mutated it to arginine (L226R), thus
matching a defective DAPK2 variant that was previously found
in a glioma cancer cell line (Barretina et al., 2012). As a detailed
characterization of purified full-length hDAPK2 (hDAPK2 FL) was
not possible due to known degradation problems in the C-termi-
nal region (Patel et al., 2011), we used hDAPK2 CD + ARD var-
iants without this tail for further experiments, identical to that
used for crystallization.
DAPK2 Dimer Interface Mutations Lead to
Monomerization in Solution
We first investigated these hDAPK2 mutants by analytical size-
exclusion chromatography (SEC) (Figure 4A). Based on the re-
sulting recursive line fitting of calibration standards (Figure S3),Structure 24, 851–861, June 7, 2016 853
Figure 2. The Homodimeric Assembly of
hDAPK2 CD + ARD Involves Two Major
Surface Areas Termed ‘‘Hydrophobic Patch
Interface’’ and ‘‘Basic Loop Interface’’
Thehydrophobicpatch (HP) interfaceandbasic loop
(BL) interface are colored in orange/yellow and
green, respectively. All other color codes are as in
Figure 1. The topology scheme from Figure 1 has
been included as reference for each monomer. The
orientation of the DAPK2 dimer is different from
Figure 1 to optimize the view into the dimeric inter-
face. The lower panels zoom into the two interface
patches, indicatingkey interface residuesdiscussed
in the text (cf. Figure 3 and Table S2). Interface
hydrogen bonds are shown in by red dashed lines.we calculated the retention volumes for monomeric and dimeric
hDAPK2. Our experimental data on wild-type (WT) hDAPK2 re-
vealed a peak maximum close to the calculated volume of the
hDAPK2 dimer. As expected, all hDAPK2 mutants analyzed
showed a significant peak shift toward larger retention volumes,
indicating loss of dimerization. The strongest effect was seen
with the hDAPK2BLmutant, which yielded close to the expected
retention volume of hDAPK2 monomers. The effects we found
for the hDAPK2 D220K and L226R mutants are similar to
those observed for the hDAPK2 BL mutant. Although the shifts
in elution volume were significant, the resolution of the SEC
approach was insufficient to resolve separate peaks arising
from a mixture of different association states.
To further quantify the oligomeric composition of selected
hDAPK2 variants, we performed small-angle X-ray scattering
(SAXS) measurements (Figure 4B; for experimental details,
see Table 2). For WT hDAPK2, no reasonable fits to either
hDAPK2 dimers or monomers were provided by computed
scattering curves from different atomic models (for details on
software used, see Supplemental Experimental Procedures).
The observed discrepancy values in Table S3 indicate that
neither of the two association states provides a matching
model. However, a significant improvement in fit was achieved
when an equilibrium mixture was used to describe the data.
The fitting procedure identified a mixture of 51% hDAPK2
monomer and 49% hDAPK2 dimer as the best solution (Table
S3; for details on software used see Supplemental Exper-
imental Procedures). By contrast, the hDAPK2 BL mutant
was found to be predominantly monomeric (89%). The D220K
mutant shows intermediate properties and is well described
as an equilibrium mixture of 68% monomers and 32% dimers.
In summary, our SEC and SAXS data show that a substantial
fraction of hDAPK2 is dimeric in solution under these experi-
mental conditions, and modifications in the conserved interface
disrupt dimerization.854 Structure 24, 851–861, June 7, 2016Diverging Dimerization Properties
of DAPK2 Mutants Suggest
Additional Regulatory Effects
To validate our structural and solution
data on hDAPK2 dimerization in a cellular
environment, we tested our hDAPK2 con-
structs using bimolecular fluorescence
complementation (BiFC) in HEK293Tcells. This assay also allowed us to investigate any effects of
endogenous Ca2+/CaM binding on hDAPK2 dimerization. To
address a possible role of the hDAPK2 C-terminal tail in
additional hDAPK2 dimerization (Shani et al., 2001), we first
compared the BiFC readout of hDAPK2 FL andC-terminally trun-
cated hDAPK2 CD + ARD (Figure 4C; for analysis of expression
levels see Figure S4). The level of dimerization in hDAPK2 CD +
ARD was about half that of hDAPK2 FL, which is in agreement
with previous data (Shani et al., 2001). To remove any potential
effects from the C-terminal tail that is found in hDAPK2 only,
we performed all remaining BiFC experiments with truncated
hDAPK2 CD + ARD variants.
Next, we tested the possible effects of Ca2+/CaM on hDAPK2
dimerization (Figure 4C). As a control, we first used the previ-
ously established hDAPK2 ARD mutants S308A and W305D,
which have been shown to either promote or substantially
reduce Ca2+/CaM binding, respectively (de Diego et al., 2010;
Shani et al., 2001). Whereas the hDAPK2 S308A variant did
not change the BiFC readout significantly, the hDAPK2 W305D
mutant increased the BiFC signal more than 5-fold. These
data indicate that endogenous Ca2+/CaM suppresses hDAPK2
dimerization provided that Ca2+/CaM binding is not impaired.
The BiFC signal exhibited a markedly reduced level of dimeriza-
tion for the hDAPK2 D220K and L226R variants, in agreement
with the solution data (Figures 4A and 4B). However, the hDAPK2
BLmutant shows an almost 3-fold increase in hDAPK2 dimeriza-
tion, in contrast to the findings on the same hDAPK2 mutant in
solution. In line with our data from the hDAPK2 W305D mutant,
showing an increase of DAPK2 dimerization due to impaired
Ca2+/CaM binding, we hence speculated that there might be a
measureable defect in Ca2+/CaM binding by the hDAPK2 BL
mutant. This is supported by our earlier structural data on the
Ca2+/CaM complex of the related hDAPK1, in which residues
from the BL are indeed involved in specific interactions with
Ca2+/CaM (Figure 3) (de Diego et al., 2010).
Figure 3. The Structurally Conserved DAPK
Homodimeric Interface Overlaps with the
DAPK1-Ca2+/CaM Interface
(A and B) Multiple sequence alignment (A) and
dimer surface (B) of hDAPK1 (PDB: 2XZS), hDAPK2
(PDB: 2A2A, chains A/B and C/D), and hDAPK3
(PDB: 1YRP). Secondary structural elements are
indicated and labeled according to the conven-
tions established for members of the DAPK family
(Temmerman et al., 2013). Interface residues have
been identified and characterized with PDBePISA
(Krissinel and Henrick, 2007). Residues discussed
in the text are labeled with red asterisks. DAPK
homodimeric interfaces are colored from yellow to
dark red, depending on the level of involvement
per residue. The hDAPK1 Ca2+/CaM interface is
colored from blue to purple. Residues that are not
modeled in the respective structures due to lack of
interpretable electron density are in gray. Residues
that have been mutated and used for functional
characterization are labeled in red. Homodimeric
interface regions that overlap with the Ca2+/CaM-
binding interface in hDAPK1 are boxed and
numbered I to V. For further details, see Table S2.Defects in the DAPK2 CD Dimeric Interface Affect Its
Ability to Bind Ca2+/CaM
To test the possible effects of homodimerization on hDAPK2
Ca2+/CaM binding, we designed a series of pull-down assays
using two different approaches. First, we assessed the level of
hDAPK2 Ca2+/CaM binding in solution to purified WT hDAPK2
and the hDAPK2 S308A mutant that can no longer be phosphor-
ylated at position 308. In line with previous data on hDAPK1
(Temmerman et al., 2014), the amount of Ca2+/CaM binding by
hDAPK2 S308A was around 4-fold higher than that in WT. In
the hDAPK2 W305D mutant, Ca2+/CaM binding was not detect-
able under the experimental conditions by direct protein staining
(Figure 5A). We then tested the hDAPK2 BL and D220K dimer
interface mutants. In the hDAPK2 BL mutant, Ca2+/CaM binding
was reduced to 46%of theWT protein, whereaswe found a 57%
increase of Ca2+/CaM binding in the hDAPK2 D220K variant.
In subsequent HEK293T cell experiments, we used western
blot staining instead of direct protein staining to allow detection
of DAPK2 mutants from cell lysate. Under these experimental
conditions, the pull-down amounts of WT hDAPK2 and hDAPK2
S308Awere too abundant for reliable quantitative analysis due to
the much higher sensitivity of the assay. Therefore, we used the
hDAPK2W305Dmutant that is compromised in Ca2+/CaM bind-
ing as a reference and introduced our mutations of interest into
this construct (Figure 5B). The hDAPK2W305Dmutant itself pro-
duced residual but reliable pull-down data in HEK293T cells. Wefound a substantial loss of Ca2+/CaM-
binding ability in the hDAPK2 W305D
BL mutant and an almost 2-fold increase
of Ca2+/CaM binding in the hDAPK2
W305D D220K mutant. Thus, although
different references were used for the
pull-downs in solution (WT DAPK2) and
in HEK293T cells (DAPK2 W305D), both
datasets agree in terms of loss of Ca2+/CaM binding for the BL mutant and an increase in Ca2+/CaM
binding for the D220K mutant. Taken together, our findings indi-
cate that although both mutants affect the mode of homodime-
rization as revealed by our structural and solution data (Figure 4),
only the BL mutant is impaired in Ca2+/CaM binding. This ex-
plains the contrasting behavior of the two mutants in the BiFC
assay in the presence of endogenous Ca2+/CaM.
The DAPK2 CD Plays an Essential Role in Ca2+/CaM
Binding
To further consolidate our findings on matching trends for
hDAPK2 Ca2+/CaM binding in solution and in cell lines, we
measured the Ca2+/CaM affinity of different hDAPK2 CD +
ARD variants quantitatively in solution by fluorescence anisot-
ropy (FA) with CrAsH-tagged calmodulin (Figures 5C and 5D).
We first used the hDAPK2 S308A mutant, in which Ser308
phosphorylation is impaired and thus all sample is expected
to bind Ca2+/CaM. We estimated its affinity to Ca2+/CaM to
be <3.5 nM. When this mutant was combined with the hDAPK2
D220K and L226R interface mutants, the binding affinity to
Ca2+/CaM was still <3.5 nM, demonstrating that neither of these
hDAPK2 variants negatively affects Ca2+/CaM binding. By
contrast, when combined with the BL mutations, the hDAPK2
S308A, BL mutant showed only a residual change in anisot-
ropy that did not allow its binding affinity to Ca2+/CaM to be
quantified.Structure 24, 851–861, June 7, 2016 855
Figure 4. Characterization of hDAPK2
Dimerization Properties
(A) SEC analysis of DAPK2 CD + ARD WT (black)
and mutants (BL, green; D220K, orange; L226R,
yellow). Calculated retention volumes for dimeric
and monomeric hDAPK2 are indicated.
(B) SAXS experimental curves and model fitting of
selected hDAPK2 mutants (for further details, see
Table 2 and Table S3). Blue dashed lines, calcu-
lated monomer fit; red dashed lines, calculated
dimer fit; solid lines (WT, black; D220K, orange; BL,
green), calculated equilibrium fit. Y axis values have
been manually offset to allow data comparison.
Error bars represent the SE of the mean scattering
intensities detected at each pixel by the photon
counting detector.
(C) Dimerization of hDAPK2 mutants by bimolec-
ular fluorescence complementation (BiFC). Left
panel: representative images; right panel: quanti-
fication of the BiFC readout normalized to protein
expression (see Figure S4). Errors bars represent
SDs from two independent experiments. Scat-
tering real-space distance distributions are shown
in Figure S5.We next tested the hDAPK2 W305D mutant that is impaired in
ARD-mediated Ca2+/CaM binding (Figure 5D), which we used as
a reference in the cellular Ca2+/CaMpull-down assays described
above (Figure 5B). This variant has an estimated Ca2+/CaM-
binding affinity of 12.5 ± 0.6 mM, which is at least 3,500-fold
weaker than that measured for hDAPK2 S308A. This hDAPK2
variant combined with the dimer interface mutants D220K or
L226R binds Ca2+/CaM with slightly stronger affinity values of
KD = 9.7 ± 1.9 mM (D220K) and KD = 2.7 ± 0.1 mM (L226R). The
modest improvement in binding affinity is probably due to the in-
crease of monomeric hDAPK2, as observed in our solution and
BiFC data (Figure 4). By contrast, no affinity value could be deter-
mined for the hDAPK2 W305D, BL variant, which confirms the
direct involvement of the BL in CD-mediated Ca2+/CaM binding.
In agreement with our pull-down data, the FA data also show that
impairment of ARD-mediated Ca2+/CaM interactions as illus-
trated by the hDAPK2 W305D mutant substantially reduces the
Ca2+/CaM-binding affinity by at least three orders of magnitude
but does not abolish it. As all known kinase structures in the
presence of Ca2+/CaM possess an 1:1 stoichiometry of kinase-
Ca2+/CaM interactions (de Diego et al., 2010; Rellos et al.,
2010), these data indicate a coupled CD-mediated and ARD-
mediated interaction to the same Ca2+/CaM module.
hDAPK2 Activity Is Regulated by Coupled Ability for
Dimerization and Ca2+/CaM Binding
Finally, we investigated how the observed coupling of hDAPK2
dimerization and Ca2+/CaM-binding ability affects hDAPK2 ac-
tivity using a well-established blebbing assay in HEK293T cells
(Bovellan et al., 2010). In this assay, the hDAPK2-mediated
phosphorylation of myosin light chain 2 causes a reorganization
of the actin cytoskeleton protruding membrane to form blebs.
The number of cells undergoing membrane blebbing can be
quantified to reflect hDAPK2 activity (Inbal et al., 2002). All exper-
iments were carried out in the absence and presence of thap-
sigargin (TG) (Figure 6A), which promotes Ca2+/CaM binding856 Structure 24, 851–861, June 7, 2016(Hoyer-Hansen et al., 2007). As expected, the addition of TG
increased blebbing of hDAPK2-expressing cells by more than
3-fold within 5 min. This effect was equally observed regardless
of whether hDAPK2 FL or truncated hDAPK2 CD + ARD was
used, in line with earlier data (Shani et al., 2001). The activity
of the hDAPK2 S308A mutant in the absence of TG is similar
to that of WT hDAPK2 in the presence of TG. This indicates
that when residue 308 can no longer be phosphorylated and
ARD-mediated Ca2+/CaM binding can occur, the presence of
endogenous Ca2+/CaM in HEK293T cells is sufficient to promote
unrestrained hDAPK2-mediated blebbing. By contrast, bleb-
bing is largely impaired in the hDAPK2 W305D mutant, even in
the presence of TG, as ARD-mediated Ca2+/CaM binding is
abolished.
The hDAPK2 D220K mutant is as active as WT hDAPK2 in
the presence of TG. Moreover, in the absence of TG its activity
is even markedly enhanced compared with WT hDAPK2, ap-
proaching the effects seen in hDAPK2 S308A. As this hDAPK2
mutant leads to weakening of the hDAPK2 dimer interface
without negatively affecting Ca2+/CaM binding, we assume
that in the D220K variant, CD residues from the BL that are
crucial for CD-mediated Ca2+/CaM interactions become more
accessible to bind endogenous Ca2+/CaM in HEK293T cells
and promote activity. However, this effect is suppressed when
the D220K mutation is combined with the W305D mutation,
which is in agreement with our FA data, and suggests that
Ca2+/CaM binding is dominated by ARD-mediated interactions.
Residual blebbing activity of the hDAPK2 BL mutant remained
even below that measured for the hDAPK2 W305D mutant both
in the absence and presence of TG, which reconfirms the essen-
tial role of the BL in hDAPK2 Ca2+/CaM binding. Activity of the
hDAPK2 BL mutant could not be restored by combining it with
either hDAPK2 S308A or hDAPK2 D220K. This is in agreement
with our FA data and demonstrates the essential role of the
hDAPK2 BL in Ca2+/CaM binding. Similarly, the blebbing activity
of the hDAPK2 L226R mutant remained residual. As hDAPK2
Table 2. SAXS Data Collection and Derived Parameters for
DAPK2 and Mutants
WT D220K BL
Data Collection Parameters
Instrument EMBL P12 (PETRA-III)
Beam geometry (mm2) 0.2 3 0.12
Wavelength (A˚) 1.24
s range (A˚1)a 0.003–0.45
Exposure time (s) 0.045$20
Sample concentration
(mg/ml)
2.0–15.0 2.0–15.0 2.0–15.0
Temperature (K) 283
Structural Parameters
I(0) (cm1) (from p(r)) 0.027 ±
0.001
0.025 ±
0.001
0.021 ±
0.001
Rg (A˚) (from p(r)) 26.4 ± 0.2 25.9 ± 0.2 23.4 ± 0.2
Dmax (A˚) 81 ± 5 90 ± 5 75 ± 5
Dry volume (103 A˚3)
calculatedb
45
Contrast (Dr 3 1010 cm2) 2.704
Molecular mass Mr (kDa)
(from I(0))
41 ± 5 37 ± 4 32 ± 3
Molecular mass Mr (kDa)
(from Porod volume [Vp/1.7])
59 ± 6 52 ± 5 46 ± 5
Calculated monomeric
mass Mr (kDa)
b
37.3
Software Employed
Primary data reduction Automated pipeline (Blanchet et al.,
2015)
Data processing ALMERGE, AUTORG, DATGNOM,
DATPOROD
Computation of model
intensities
CRYSOL, FFMAKER, OLIGOMER
aMomentum transfer jsj = 4psin(q)/l.
bCalculated from the sequence using www.basic.northwestern.edu/
biotools/proteincalc.html.Ca2+/CaM binding is not affected in this mutant (Figures 5C and
5D), the most plausible explanation is that L226 is involved in
protein-substrate binding during catalysis, as this residue is sit-
uated close to the substrate-binding site (Figure 3) (Temmerman
et al., 2013). In summary, our data demonstrate that DAPK2 cat-
alytic activity is regulated byCa2+/CaM interactions with both the
ARD and the BL of the CD, thus coupling the hDAPK2 ability
for dimerization and Ca2+/CaM binding with hDAPK2 function
(Figure 6B).
DISCUSSION
We have identified and characterized a new type of serine/thre-
onine kinase CD-mediated homodimeric arrangement that is
shared by the three most closely related members of the DAPK
family: DAPK1, DAPK2, andDAPK3 (Figure 1). Such an assembly
has not been found in any other protein kinases and hence
seems to be driven by specific DAPK features, such as the BL
signature motif. It is different from the previously found dimeriza-tion arrangement via swapping of the activation loop between
two adjacent kinase domains (Oliver et al., 2007; Pike et al.,
2008).
DAPK Ca2+/CaM binding and activity is associated with
the disassembly of the homodimer into the monomeric state.
When investigating the effect of CDmonomerization on hDAPK2
activity in more detail, we found a second micromolar-affinity
Ca2+/CaM-binding site that indeed originates from the BL (Fig-
ure 5). Comparison of the specific interactions found in these
two sites reveals that the ARD-mediated interactions with
Ca2+/CaM are muchmore extensive. This explains why the affin-
ities of the two interaction sites vary by more than three orders of
magnitude (Figures 5C and 5D). These data also confirm the un-
usual versatility of CaM as a scaffold that is able to bind to many
proteins with different surfaces and highly adaptive conforma-
tions (Yamniuk and Vogel, 2004).
Remarkably, when the BL is mutated such that the CD-medi-
ated Ca2+/CaM interaction site is impaired, hDAPK2 Ca2+/CaM
binding is completely abolished, despite the presence of the
nM-affinity ARD-mediated Ca2+/CaM interaction site. Our data
are thus arguing in favor of a model in which ARD-mediated
Ca2+/CaM binding is not autonomous of the overall hDAPK2
structure, which was not expected based on previous data
mostly on kinase ARD peptide-Ca2+/CaM complexes (Dagher
et al., 2011; Kuczera and Kursula, 2012; Yamniuk and Vogel,
2004). Indeed, in the hDAPK1-Ca2+/CaM complex structure, it
was initially shown that ARD-mediated binding requirements
for Ca2+/CaM are different from isolated ARD peptides due to
steric clashes with the hDAPK1 CD (de Diego et al., 2010).
Thus, the interpretation of Ca2+/CaM-binding data with synthetic
ARD peptides requires caution in terms of their relevance under
physiological conditions.
As our functional analysis focused on hDAPK2, we next asked
to what extent a CD-mediated dimerization module is part of
a common regulatory mechanism for members of the DAPK
family. In the two DAPK members that are regulated by Ca2+/
CaM—hDAPK1 and hDAPK2—this mechanism would involve
the inhibition of CD-mediated dimerization, the activation of
CD-mediated and ARD-mediated Ca2+/CaM binding, and a
conserved pattern of two phosphorylation sites in the ARD
(Ser289, Ser308) with opposing effects on activity regulation
(Simon et al., 2015). An analysis of all earlier structures deposited
in the PDB reveals that indeed all available DAPK2 structures
(PDB: 1WMK, 1Z9X, 1ZWS, 2A27, and 2CKE) show the same
type of dimer assembly that we found, confirming the relevance
of the data presented here under a broad range of different
experimental conditions used for structural analysis.
By contrast, for hDAPK1 there is a substantially higher level
of diversity in terms of possible arrangements. Among the 30
deposited DAPK1 structures, we found three with an alternative
dimer interface (PDB: 1JKT, 2Y4P, and 3ZXT), which is that of the
canonical serine/threonine kinase dimer arrangement by activa-
tion segment exchange (Pike et al., 2008). Several other hDAPK1
PDB entries are even monomeric. This is supported by a
comparative SEC experiment under the conditions we have es-
tablished here showing that hDAPK1 tends to be considerably
more monomeric than hDAPK2 (Figure S3). An analysis of
the level of specific dimeric interface interactions indicates
an almost complete lack in the hDAPK1 dimer, compared withStructure 24, 851–861, June 7, 2016 857
Figure 5. CD-Mediated Ca2+/CaM Binding in
hDAPK2
(A) CaM pull-down assays of purified hDAPK2
variants monitored by SDS-PAGE Coomassie blue
staining. ND, not determined. Data are normalized
to the hDAPK2 S308A mutant. Error bars represent
one SD from three experimental repetitions.
(B) CaM pull-down assays of hDAPK2 variants
HEK293T transfected cells monitored by western
blot. Data are normalized to the hDAPK2 W305D
mutant. I, cell input; E, EGTA-mediated elution on
Sepharose 4B-CaM; C, EGTA-mediated elution on
Sepharose 4B without CaM (negative control).
Relative units were calculated using the average
ratio between input and elution band intensities for
each mutant over three replicates. Error bars
represent one SD from three experimental repeti-
tions.
(C and D) In vitro fluorescence anisotropy assays of
purified hDAPK2 variants titrated against Ca2+/
CrAsH-CaM. Error bars represent one SD between
the triplicates of a representative experimental
curve. KD values were estimated using a non-linear
regression assuming one-site specific binding with
the software Prism (version 5.0, GraphPad) for
three experiments.those found in hDAPK2 (Table S2). Therefore, we speculate that
the inhibition of CD-mediated homodimerization of hDAPK1may
have a less pronounced role in regulating hDAPK1 activity than
other family members.
We next investigated whether the complementation of the
high-affinity ARD-mediated Ca2+/CaM binding by the BL-medi-
ated Ca2+/CaM-binding site is generally applicable to other
Ca2+/CaM-regulated protein kinases. The highly conserved
pattern of four positively charged BL residues in DAPK1 and
DAPK2 (Figure 3) is suggestive of a common CD-mediated
Ca2+/CaM-binding site in both these kinases. Our previous struc-
tural data on the hDAPK1-Ca2+/CaM complex (de Diego et al.,
2010) together with the hDAPK2 Ca2+/CaM-binding data from
this work support this hypothesis.
Moreover, our findings are mirrored in CaMKII in terms of a
generally applicable mechanism of dual low- and high-affinity
Ca2+/CaMbinding. In this prototype kinase, the ARD high-affinity
Ca2+/CaM-binding site is occluded from the dodecameric as-
sembly of the unphosphorylated holoenzyme (Chao et al.,
2011). CaMKII phosphorylation of Thr286, located in a loop
N-terminal to the canonical ARD high-affinity Ca2+/CaM interac-
tion site, leads to a 1,000-fold increase in Ca2+/CaM-binding af-
finity, described as Ca2+/CaM trapping (Meyer et al., 1992). This
triggers a cascade of phosphorylation of further ARD residues,
followed by Ca2+/CaM disassembly and acquisition of Ca2+-
independent kinase activity, which has been described as an
autonomous activity state (Stratton et al., 2013). Given that
the high-affinity ARD-mediated Ca2+/CaM interaction site is
conserved in CaMKII and DAPK2 and in both kinases a low-affin-
ity Ca2+/CaM-binding state can be detected, it may be inter-
esting to reveal to what extent there are analogies. Confor-
mation-dependent accessibility of known sites for Ca2+/CaM
binding seems to be a crucial parameter. However, since in
the structure of the CaMKII CD + ARD-Ca2+/CaM complex
the ARD-Ca2+/CaM module is entirely separate (Rellos et al.,858 Structure 24, 851–861, June 7, 20162010), ultimately this question can probably only be resolved
by a still awaited structure of the CaMKII holo-Ca2+/CaM
complex.
Taking earlier data and those of this contribution together, we
propose an extended model of DAPK activity regulation, which
so far has been fully demonstrated here for hDAPK2 (Figure 7).
It builds on previously established general mechanisms of regu-
lation, including ARD phosphorylation, ARD-mediated Ca2+/
CaM binding, and conformational switches in the CD region
covering helix aD (de Diego et al., 2010; Shani et al., 2001; Simon
et al., 2015). In our extendedmodel, themonomeric state of a dy-
namic dimer/monomer equilibrium is the active form that allows
CD-mediated Ca2+/CaM binding (Figure 7, steps 1 and 2). This
equilibrium may vary between different members of the DAPK
family in which dimerization has been observed, as indicated
by our structural comparison above. BL-mediated Ca2+/CaM
interactions are a prerequisite for high-affinity ARD-mediated
Ca2+/CaM binding (Figure 7, step 3), resulting in a structural
arrangement found previously (de Diego et al., 2010). What hin-
ders autonomous ARD-mediated Ca2+/CaM interactions in the
absence of CD-mediated Ca2+/CaM binding at the molecular
level is not yet fully understood. This could result from pseudo-
substrate-type interactions of the N-terminal part of the ARD
with the CD active-site area, as observed in various CD + ARD
structures of members of the DAPK family, which may occlude
the ARD segment from being accessible for Ca2+/CaM binding.
Independently from this, Ser308, which serves as one of the
key ARD-Ca2+/CaM interactions sites, must not be phosphory-
lated. The last step (Figure 7, step 4), full activation of DAPK
through the release of the Ca2+/CaM-bound ARD module from
the CD surface, is required to allow full access of protein sub-
strates, but this step still needs to be verified by structural
data. Based on the structure of the hDAPK1-Ca2+/CaM complex
(de Diego et al., 2010), Ser289 phosphorylation would inevitably
lead to such a fully active state, which is supported by recent
Figure 6. hDAPK2Blebbing Assay in HEK293T
Cells in the Absence and Presence of Thapsi-
gargin
(A) Error bars indicate one SD. All experiments
were performed in triplicate. Representative images
of HEK293T cells expressing hDAPK2 variants are
shown below. ND, not determined.
(B) Schematic representation outlining our findings
on how homodimerization, Ca2+/CaM binding, and
cellular activity of hDAPK2 are coupled. The thick-
ness of the arrows representing the dimer/monomer
equilibrium of different hDAPK2 mutants indicates
shifts measured by SEC and SAXS (cf. Figure 4).data on hDAPK2 (Isshiki et al., 2012). Whether this is accompa-
nied by a conformational change in ARD-bound Ca2+/CaM, as
observed in several kinase ARD peptide-Ca2+/CaM complexes,
also remains to be determined.
Our data agree with other established kinase dimerization
models that functionally couple dimerization with activity regula-
tion (Endicott et al., 2012). However, whereas dimerization by
activation segment swapping in other serine/threonine protein
kinases promotes specific activation upon segment phosphory-
lation (Oliver et al., 2007; Pike et al., 2008), there is no phosphor-
ylation site in the equivalent sequence segment in hDAPK1 and
hDAPK2. Our data are restricted to one member of the DAPK
family (hDAPK2) and only take the CD and ARD segments into
account. All members of the DAPK family investigated here—
DAPK1, DAPK2, andDAPK3—have additional domain segments
in their C-terminal regions with unrelated oligomerization proper-
ties, and an overall model for their involvement in regulation has
been proposed (Shiloh et al., 2014).
The logical next step will be to investigate our findings in the
context of the respective full-length DAPK proteins. From a
potential drug discovery point of view, these additional sites
for activity regulation could provide promising starting points
for the rational design of novel inhibitors.
Significance
About 15% of all human protein kinases are estimated to be
regulated by calcium-bound calmodulin (CaM), demonstrating
the significance of connecting calcium-dependent and phos-
phorylation-dependent signaling processes. Common to most
of those kinases is that CaM is bound to a small, separate, and
highly conserved autoregulatory segment C-terminal to the ki-
nase domain. Previous data indicated that CaM binding to this
segment is modular and independent from the neighboring
kinase domain, raising questions regarding how this could be
coupled with other known mechanisms of kinase activity regula-
tion. In this study, we searched for mechanistic principles of con-
necting different types of kinase activity regulation such asphosphorylation and oligomerization by
investigating CaM-regulated members of
the DAPK family. In DAPK2, which we
took as a model, we discovered a novel
CaM-binding site mediated by a common
DAPK family signature loop with low-
micromolar affinity. As this loop is also
involved in DAPK2 kinase dimerization,
monomerization promotes CaM binding. Surprisingly, when
this kinase-mediated CaM-binding site is impaired there is also
no CaM binding to the well-established autoregulatory segment,
challenging previous assumptions on modular, autonomous
CaM binding to regulate kinase activity. Our data generate an
integrated four-stepmodel in DAPK activity regulation: (1) kinase
domain-mediated homo-dimerization, (2) kinase-mediated CaM
binding, (3) autoregulatory segment-mediated CaM binding, and
(4) DAPK phosphorylation of specific residues sites. Comparison
of our findings with other prototype CaM-dependent protein ki-
nases is indicative that dual and coupled CaM-mediated kinase
activity regulation could present a general principle of kinase
activity regulation. The discovery of the kinase-mediated CaM-
binding site opens novel opportunities for targeting this site
by small-molecular inhibitors and subsequent drug discovery
approaches.
EXPERIMENTAL PROCEDURES
The hDAPK1 construct comprising the CD and most of the autoregulatory
domain (CD+ARD, residues 1–312) was expressed fromapET9a-derived vec-
tor encoding an N-terminal hexahistidine tag with a tobacco etch virus (TEV)
cleavage site in Escherichia coli BL21(DE3) strain induced with 0.1 mM isopro-
pyl b-D-1-thiogalactopyranoside (IPTG) and grown at 25Covernight. The cells
were lysed using a microfluidizer in 50 mM Tris-HCl (pH 8.0), 300 mM NaCl,
5 mM imidazole, 5 mM b-mercaptoethanol, protease inhibitor cocktail (Com-
plete, Roche Life Science) and 1/1,000-fold diluted benzonase (Novagen).
The lysateswere centrifuged at 76,5003g for 30min and the supernatant incu-
batedwith 500ml of Ni-nitrilotriacetic acid (NTA) resin (Qiagen) overnight at 4C.
The resin was collected by centrifugation at 2003 g for 1min and resuspended
in 5 ml of lysis buffer. It was then loaded on gravity columns and washed first
with 10 volumes of buffer A (50 mM HEPES-NaOH [pH 8.0], 1,000 mM NaCl,
10 mM imidazole, and 1 mM DTT) followed by 20 volumes of buffer B (50 mM
HEPES-NaOH [pH 8.0], 100 mM NaCl, 50 mM imidazole, and 1 mM DTT).
The protein was eluted with buffer B containing imidazole in steps of 100,
200, 300, and 400 mM. The purified fractions were centrifuged for 10 min at
20,817 3 g at 4C and 5 mg of protein was incubated with 50 mg of hexahisti-
dine-tagged TEV protease for 8 hr at room temperature. The protein was dia-
lyzed to remove imidazole in buffer (50 mM Tris-HCl [pH 8.0], 100 mM NaCl,
and1mMDTT) for 1 hr at room temperature and theTEVproteasewas removedStructure 24, 851–861, June 7, 2016 859
Figure 7. General Mechanism of DAPK Ac-
tivity Regulation
CD-mediated monomerization (step 1), micro-
molar-affinity CD-mediated Ca2+/CaM binding
(step 2), and nanomolar-affinity ARD-mediated
Ca2+/CaM binding (step 3). Step 4—release of
the Ca2+/CaM-bound ARD module—has not yet
been mechanistically investigated and is therefore
labeled with a ‘‘?’’. For reasons of clarity, effects on
DAPK activity regulation by ARD phosphorylation
are not included in this scheme. Color codes are
as in Figures 1 and 2. The DAPK CD active site is
indicated with a star. As extracted from available
structural data the ARD helix, shown by a cylinder,
is formed upon Ca2+/CaM binding.with a second Ni-NTA column. Finally, the protein was subjected to SEC with
S200 10/300 Gl (Amersham, GE Healthcare).
For hDAPK2 and hDAPK3, the respective cDNA was amplified from their
pcDNA vector by PCR (Shani et al., 2001). The products, corresponding to
hDAPK2 comprising the CD and autoregulatory domain (CD + ARD, residues
10–330) and hDAPK3 comprising the CD (CD, residues 1–274), were subcl-
oned into the Gateway system (Invitrogen) vector pDEST-15, with an N-termi-
nal glutathione S-transferase tag. The recombinant proteins were expressed in
the E. coliRosetta (DE3) pLysS strain at 20C, inducing with 0.4mM IPTGover-
night. The cell pellet was resuspended in 20 mM HEPES (pH 7.5) and 150 mM
NaCl, after lysis and centrifugal clarification. The recombinant protein in the
supernatant was bound to glutathione Sepharose-4B (GE Healthcare). After
washing with 10 column volumes of lysis buffer, elution was performed by
TEV protease cleavage. Both proteins were further purified by SEC using an
S75 10/600 Gl column (GE Healthcare).
For analytical SEC, SAXS, and CaM pull-down and FA assays, hDAPK2
CD + ARD was amplified from its pcDNA vector (Shani et al., 2001) by PCR
and cloned into pETM14 for expression in E. coli BL21 (DE3) star pRARE2.
Cells were grown in Terrific Broth medium containing 30 mg/ml kanamycin
and 34 mg/ml chloramphenicol at 37C to a maximal optical density of 1.0–
1.2 at 600 nm. Protein expression was induced by 0.1 mM IPTG at 20C for
20 hr. Cells were harvested and sonicated in 50 mM HEPES-NaOH (pH 7.5),
250 mM NaCl, 5% (v/v) glycerol, 5 mM CaCl2, 10 mM imidazole (pH 7.5),
0.2 mM tris(2-carboxyethyl)phosphine (TCEP), 1 mg/ml DNAseI, 10 mg/ml
lysozyme, and protease inhibitors (Pefabloc SC, Roche Life Science). The ly-
sates were centrifuged at 24,000 3 g for 30 min at 4C and the supernatants
were filtered and applied to an Ni-NTA resin (Qiagen). Proteins were eluted
with 50 mM HEPES-NaOH (pH 7.5), 250 mM NaCl, 5% (v/v) glycerol, 5 mM
CaCl2, 0.1 mM TCEP, and 200 mM imidazole. The hexahistidine tag was
cleaved by 3C-protease at 4C for 20 hr in 50 mM HEPES-NaOH (pH 7.5),
250 mMNaCl, 5% (v/v) glycerol, 5 mM CaCl2, 0.1 mM TCEP, and 10 mM imid-
azole. The cleaved tag was removed using Ni-NTA resin (Qiagen). The proteins
were further purified by SEC, using an S75 10/600 Gl column (GE Healthcare)
in 50mMHEPES-NaOH (pH 7.5), 250mMNaCl, 5% (v/v) glycerol, 5mMCaCl2,
and 0.1 mM TCEP. Selected fractions were collected and concentrated to a
maximum of 7 mg/ml before flash-freezing in liquid nitrogen.
Analytical SECwas used to assess the level of dimerization of hDAPK2 CD +
ARD variants. For each experiment, 100 ml of protein sample at concentra-
tions between 2.5 and 7 mg/ml were loaded on an S75 10/300 Gl column
(GE Healthcare) at a flow rate of 0.2 ml/min at 4C in 50 mM HEPES-NaOH
(pH 7.5), 250 mM NaCl, and 0.1 mM TCEP. The column was calibrated using
Bio-Rad gel-filtration standards (#151-1901) according to the manufacturer’s
recommendations. The DAPK1 CD + ARD construct used for SEC was
expressed and purified as previously described (Temmerman et al., 2014).
The hDAPK1 CD + ARD construct (1–312) was crystallized at a concentra-
tion of 6 mg/ml in 0.2 M magnesium acetate tetrahydrate, 0.1 M sodium
cacodylate (pH 6.5) with 10% (w/v) polyethylene glycol (PEG) 8000, using
the hanging-drop vapor diffusion method. The hDAPK2 CD + ARD construct
was crystallized at a concentration of 6 mg/ml using the sitting-drop vapor
diffusion method. The solution used for crystallization contained 0.2 M lithium
sulfate, 0.1 M Tris-HCl (pH 8.5), 25% (w/v) PEG 4000, and 15% (v/v) glycerol.860 Structure 24, 851–861, June 7, 2016The hDAPK3 CD construct was crystallized at a concentration of 5 mg/ml by
the hanging-drop vapor diffusion method. The solution used for crystallization
consisted of 0.1 M Tris-HCl (pH 9.0), 0.2 M acetate, 30% (w/v) PEG 6000, and
10 mM DTT. The coordinates and structure factors were deposited in the PDB
under the accession codes PDB: 2XZS (DAPK1), PDB: 2A2A (DAPK2) and
PDB: 1YRP. Details of X-ray structure determination are described in Supple-
mental Experimental Procedures.
Further biophysical and functional experiments were carried out with
hDAPK2. Details of analytical SEC experiments, SAXS, BiFC, calmodulin
pull-down assays, in vitro FA assays, and cellular blebbing assays are
described in Supplemental Experimental Procedures.
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